Cargando…

Validity and reliability of a novel immunosuppressive adverse effects scoring system in renal transplant recipients

BACKGROUND: After renal transplantation, many patients experience adverse effects from maintenance immunosuppressive drugs. When these adverse effects occur, patient adherence with immunosuppression may be reduced and impact allograft survival. If these adverse effects could be prospectively monitor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meaney, Calvin J, Arabi, Ziad, Venuto, Rocco C, Consiglio, Joseph D, Wilding, Gregory E, Tornatore, Kathleen M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4062516/ https://www.ncbi.nlm.nih.gov/pubmed/24925208 http://dx.doi.org/10.1186/1471-2369-15-88

Ejemplares similares

Beyond Single Nucleotide Polymorphisms: CYP3A5(∗)3(∗)6(∗)7 Composite and ABCB1 Haplotype Associations to Tacrolimus Pharmacokinetics in Black and White Renal Transplant Recipients
por: Brazeau, Daniel A., et al.
Publicado: (2020)

Association of Extrarenal Adverse Effects of Posttransplant Immunosuppression With Sex and ABCB1 Haplotypes
por: Venuto, Rocco C., et al.
Publicado: (2015)

Race and sex associations with tacrolimus pharmacokinetics in stable kidney transplant recipients
por: Tornatore, Kathleen M., et al.
Publicado: (2022)

Age associations with tacrolimus and mycophenolic acid pharmacokinetics in stable Black and White kidney transplant recipients: Implications for health inequities
por: Tornatore, Kathleen M., et al.
Publicado: (2023)

Comparison of P‐glycoprotein function in peripheral blood mononuclear cells ex vivo in stable Black and White male and female kidney transplant recipients
por: Tornatore, Kathleen M., et al.
Publicado: (2022)

Parvovirus B19 Infection due to over Immunosuppression in Kidney Transplant Recipients: Case Reports and Literature Review
por: Altheaby, Abdulrahman, et al.
Publicado: (2021)

Massive Necrotizing Pancreatitis in an Immunosuppressed Renal Transplant Recipient (Successful Therapy)
por: Slaton, Joel W., et al.
Publicado: (1993)

Immunological risk stratification and tailored minimisation of immunosuppression in renal transplant recipients
por: Phanish, Mysore K., et al.
Publicado: (2020)

Pacemaker-related Candida parapsilosis fungaemia in an immunosuppressed renal transplant recipient
por: Hebert, Josephine, et al.
Publicado: (2021)

A Test Identifying Biomarkers of Immunosuppression-Related Adverse Events in Kidney Transplant Recipients
por: Legendre, Christophe
Publicado: (2019)

Transplant of kidneys with small renal cell carcinoma in incompatible, heavily immunosuppressed recipients
por: Ali, AM, et al.
Publicado: (2012)

Personalization of the Immunosuppressive Treatment in Renal Transplant Recipients: The Great Challenge in “Omics” Medicine
por: Zaza, Gianluigi, et al.
Publicado: (2015)

Recalcitrant hyperkeratotic verrucae in a renal transplant recipient clearing with cessation of immunosuppression
por: Maor, Danit, et al.
Publicado: (2018)

Optimization of de novo belatacept‐based immunosuppression administered to renal transplant recipients
por: Kirk, Allan D., et al.
Publicado: (2020)

Renal Outcomes of Liver Transplantation Recipients Receiving Standard Immunosuppression and Early Renal Sparing Immunosuppression: A Retrospective Single Center Study
por: Sharma, Pratima, et al.
Publicado: (2019)

Reliability and Validity of the Japanese Version of the Basel Assessment of Adherence to Immunosuppressive Medications Scale in Kidney Transplant Recipients
por: Kosoku, Akihiro, et al.
Publicado: (2023)

Cost utility analysis of immunosuppressive regimens in adult renal transplant recipients in England and Wales
por: Muduma, Gorden, et al.
Publicado: (2014)

Graft loss among renal-transplant recipients with early reduction of immunosuppression for BK viremia
por: Azar, Marwan M, et al.
Publicado: (2017)

Effect of Immunosuppressive Therapy on the Occurrence of Atypical Hemolytic Uremic Syndrome in Renal Transplant Recipients
por: Raina, Rupesh, et al.
Publicado: (2018)

COVID-19 AND IMMUNOSUPPRESSION: A CASE OF COVID-19 IN A RENAL TRANSPLANT RECIPIENT
por: Boparai, Sukhmani, et al.
Publicado: (2020)

Determinants of immunosuppressive therapy in renal transplant recipients: an Italian observational study (the CESIT project)
por: Rosa, Alessandro C., et al.
Publicado: (2023)

Oxidative and Nitrosative Stress in Stable Renal Transplant Recipients with Respect to the Immunosuppression Protocol – Differences or Similarities?
por: Cvetković, Tatjana, et al.
Publicado: (2015)

The Clinical Manifestation of Immunosuppressive Therapy as a Tool to Improve Immune Monitoring in Renal Transplant Recipients
por: Scott, Noa, et al.
Publicado: (2023)

BK Virus in Kidney Transplant Recipients: The Influence of Immunosuppression
por: Barraclough, Katherine A., et al.
Publicado: (2011)

Withdrawal of Immunosuppression in Pediatric Liver Transplant Recipients in Korea
por: Lee, Jee Hyun, et al.
Publicado: (2009)

Cost of Lifetime Immunosuppression Coverage for Kidney Transplant Recipients
por: Page, Timothy F., et al.
Publicado: (2008)

Optimal Immunosuppression Strategy in the Sensitized Kidney Transplant Recipient
por: Olaso, Danae, et al.
Publicado: (2021)

Covid-19 in kidney transplant recipients with immunosuppressive therapy
por: Sheikhalipour, Zahra, et al.
Publicado: (2022)

Evidence for the Immunosuppressive Potential of Calcineurin Inhibitor-Sparing Regimens in Liver Transplant Recipients with Impaired Renal Function
por: Ide, Kentaro, et al.
Publicado: (2011)

Relationship of transitional regulatory B and regulatory T cells and immunosuppressive drug doses in stable renal transplant recipients
por: Ibrahim, Eman H, et al.
Publicado: (2021)

POS-918 ADVERSE EVENTS OF COVID-19 VACCINES IN RENAL TRANSPLANT RECIPIENTS
por: WONG, J.M., et al.
Publicado: (2022)

Predictors and Adverse Outcomes of Acute Kidney Injury in Hospitalized Renal Transplant Recipients
por: Hod, Tammy, et al.
Publicado: (2023)

Evolving concepts in the selection of immunosuppression regimen for liver transplant recipients
por: Locke, Jayme E, et al.
Publicado: (2011)

Management of Immunosuppression in Kidney Transplant Recipients Who Develop Malignancy
por: Yang, Danwen, et al.
Publicado: (2019)

Combining Sorafenib and Immunosuppression in Liver Transplant Recipients with Hepatocellular Carcinoma
por: Hussaarts, Koen G. A. M., et al.
Publicado: (2021)

Immunosuppression minimization in kidney transplant recipients hospitalized for COVID-19
por: Anton Pampols, Paula, et al.
Publicado: (2021)

Rapid Development of Syringocystadenocarcinoma Papilliferum in an Immunosuppressed Liver Transplant Recipient
por: Zilberg, Catherine, et al.
Publicado: (2022)

Antineoplastic chemotherapy and immunosuppression in liver transplant recipients: Squaring the circle?
por: Coupier, Antoine, et al.
Publicado: (2022)

Targets of new immunosuppressants in renal transplantation
por: Cruzado, Josep M, et al.
Publicado: (2011)

Immunosuppressants in renal transplant—An offender for bronchospasm!
por: Kaur, Gurpreet, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_noe35pfc7nlmt9lies3iaqlnpf